Tilray Brands, Inc. (TLRY) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tilray Brands, Inc. (TLRY:NASDAQ), powered by AI.

Current Price
$4.88
P/E Ratio
-0.2
Market Cap
434M
Sector
Healthcare
What is the Tilray Brands, Inc. stock price forecast?

Tilray Brands, Inc. is currently trading at $4.88. View real-time AI analysis on Alpha Lenz.

What is Tilray Brands, Inc. insider trading activity?

View the latest insider trading data for Tilray Brands, Inc. on Alpha Lenz.

What is Tilray Brands, Inc.'s P/E ratio?

Tilray Brands, Inc.'s P/E ratio is -0.2.

Tilray Brands, Inc.

NASDAQ · TLRY
$4.88-0.13(-2.59%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Tilray Brands, Inc.'s future dividend policy...
Alpha Chat Insight

Tilray Brands, Inc. trades at a P/E of -0.2 (undervalued) with modest ROE of -88.3%.

Ask for details

Company Overview

Tilray Brands Inc. is a pioneering player in the emerging global cannabis industry. A diversified company, it engages in the research, cultivation, production, and distribution of cannabis and hemp-based products. Tilray's primary function is to develop, produce, and distribute a wide range of medicinal and recreational cannabis products, including dried flower, extracts, and edibles. The company also produces hemp foods and alcoholic beverages. Founded in 2013, Tilray has rapidly gained a significant foothold, serving both medical patients and recreational consumers in multiple countries, including Canada, the United States, and parts of Europe. Tilray Brands Inc. operates within an industry that intersects with pharmaceuticals, consumer goods, and agriculture, heavily impacting sectors such as healthcare, wellness, and food and beverages. Through strategic acquisitions and partnerships, Tilray broadens its product offerings and global market presence. Its emphasis on research and innovation propels its market significance, especially as the demand for alternative wellness products grows. With the cannabis sector continuing to evolve, Tilray is poised as a key contributor to shaping market dynamics, establishing itself as a reputable brand committed to high-quality cannabis and cannabinoid-based products.

CEOMr. Irwin David Simon
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees2,842

Company Statistics

FY 2025

Profile

$434.48MMarket Cap
$821.31MRevenue
0.00Shares Out
2,842Employees

Margins

29.29%Gross
2.37%EBITDA
-13.13%Operating
-280.33%Pre-Tax
-265.60%Net

Valuation

-0.20P/E
0.29P/B
0.53EV/Sales
26.75EV/EBITDA
-3.41P/FCF

Growth (CAGR)

9.34%Rev 3Yr
24.11%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-69.29%ROA
-88.27%ROE
-71.82%ROIC

Financial Health

$221.67MCash & Cash Equivalents
$363.09MNet Debt
39.26%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Tilray Brands, Inc. (ticker: TLRY) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 2,842 employees. Market cap is $434M.

The current price is $4.88 with a P/E ratio of -0.2x and P/B of 0.29x.

ROE is -88.27% and operating margin is -13.13%. Annual revenue is $821M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Tilray Brands, Inc. (TLRY) Stock Forecast 2026 $4.88 — Price, Financials & Analyst Targets | Alpha Lenz